These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 38754401

  • 1. Association of the Complement Factor H Y402H Polymorphism and Response to Anti-Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration: An Updated Meta-Analysis.
    Roshanshad A, Moosavi SA, Arevalo JF.
    Ophthalmic Res; 2024; 67(1):358-386. PubMed ID: 38754401
    [Abstract] [Full Text] [Related]

  • 2. Association of the polymorphism Y402H in the CFH gene with response to anti-VEGF treatment in age-related macular degeneration: a systematic review and meta-analysis.
    Hong N, Shen Y, Yu CY, Wang SQ, Tong JP.
    Acta Ophthalmol; 2016 Jun; 94(4):334-45. PubMed ID: 27151934
    [Abstract] [Full Text] [Related]

  • 3. Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis.
    Chen G, Tzekov R, Li W, Jiang F, Mao S, Tong Y.
    Sci Rep; 2015 Sep 28; 5():14517. PubMed ID: 26411831
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic Variants of Complement Factor H Y402H (rs1061170), C2 R102G (rs2230199), and C3 E318D (rs9332739) and Response to Intravitreal Anti-VEGF Treatment in Patients with Exudative Age-Related Macular Degeneration.
    Kubicka-Trząska A, Żuber-Łaskawiec K, Dziedzina S, Sanak M, Romanowska-Dixon B, Karska-Basta I.
    Medicina (Kaunas); 2022 May 13; 58(5):. PubMed ID: 35630075
    [Abstract] [Full Text] [Related]

  • 9. Comparison of ARMS2/LOC387715 A69S and CFH Y402H risk effect in wet-type age-related macular degeneration: a meta-analysis.
    Jabbarpoor Bonyadi MH, Yaseri M, Nikkhah H, Bonyadi M, Nazari R, Soheilian M.
    Int Ophthalmol; 2019 Apr 13; 39(4):949-956. PubMed ID: 29423786
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Age-related macular degeneration and association of CFH Y402H and LOC387715 A69S polymorphisms in a Turkish population.
    Soysal Y, Inan UÜ, Küsbeci T, Imirzalioğlu N.
    DNA Cell Biol; 2012 Mar 13; 31(3):323-30. PubMed ID: 21790300
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CFH Y402H and VEGF Polymorphisms and Anti-VEGF Treatment Response in Exudative Age-Related Macular Degeneration.
    Kepez Yildiz B, Ozdek S, Ergun MA, Ergun S, Yaylacioglu Tuncay F, Elbeg S.
    Ophthalmic Res; 2016 Mar 13; 56(3):132-8. PubMed ID: 27404493
    [Abstract] [Full Text] [Related]

  • 20. Photodynamic therapy in VEGF inhibition non-responders-Pharmacogenetic study in age-related macular degeneration assessed with swept-source optical coherence tomography.
    Teper SJ, Nowinska A, Pilat J, Wylegala E.
    Photodiagnosis Photodyn Ther; 2016 Mar 13; 13():108-113. PubMed ID: 26780119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.